Burns, PIH, Hypopigmentation, Erythema, and Scarring

Status: draft compiled 2026-04-20.

Epidermal injury is the commonest laser hair removal complication and the one most amenable to prevention. It ranges from the expected and transient (erythema, perifollicular edema) through the cosmetically significant (PIH, hypopigmentation) to the rare and permanent (scarring). The mechanism for every entry in this category is epidermal thermal injury — either directly from beam absorption or secondarily from delayed heating, inflammation, and healing dysregulation.

Expected and desired: erythema and perifollicular edema

Immediately post-pulse, the treated field should develop mild-to-moderate erythema with small pink-red bumps around treated follicles (perifollicular edema). This is the desired endpoint; it indicates that beam energy reached the follicle and produced the intended inflammatory response. The reaction resolves over 24-72 hours with cool compresses and bland emollient. No treatment needed beyond routine post-session care. Sources: Lanigan 2006 Dermatol Surg, PMID 16816888; Haedersdal 2006 CD004684. Confidence: C1.

An erythema rate of 58% across ≥6-session courses is typical in pooled trial data. Absence of erythema after a session usually indicates sub-therapeutic fluence and suggests parameter adjustment upward for the next session.

Burns

True burns — blistering, frank skin injury within hours — are uncommon (1-2% or less in pooled series) but preventable. Causes: excessive fluence for the skin type, inadequate cooling, beam overlap with repeated passes, failure to shave pre-session (beam heats above-surface stubble producing superficial burns), treatment over tanned or recently sun-exposed skin, mismatched wavelength (alexandrite on Fitz V), and product residue on skin that absorbs beam energy.

Management: cool compresses for acute injury; topical antibiotic (mupirocin or topical silver sulfadiazine) for open wounds; bland emollient for closed injury; low-potency topical steroid if inflammatory component prominent; wound care per standard burn protocols; dermatology referral for anything above superficial first-degree. Most burns heal in 1-3 weeks but may leave PIH or, rarely, scarring. Sources: Lanigan 2006; Dermatology Times laser burns coverage. Confidence: C2.

Post-inflammatory hyperpigmentation (PIH)

PIH is the commonest cosmetically significant complication on Fitzpatrick IV-VI and the single largest clinical differentiator between wavelength choices on darker skin. Mechanism: inflammatory cytokines (tumour necrosis factor α, interleukins) released in response to the thermal injury stimulate dermal and epidermal melanocytes to increase melanin production, producing persistent pigmented macules in the treated field.

Rate by wavelength in dark skin: Nd:YAG 2-3% (Fitz V-VI); diode 5-10%; alexandrite 10-19%; ruby ≥20%. One Black-skin alexandrite cohort reported 28%. Dorgham 2020 meta-analysis, PMID 31587390 supports Nd:YAG preference on this endpoint.

Management: strict photoprotection is the foundation (mineral SPF 30+, iron-oxide-tinted sunscreen for visible-light protection in darker skin); topical hydroquinone 2-4% cycled 4-8 weeks on then break; azelaic acid 15-20%; tretinoin 0.025-0.1%; niacinamide 4-5%; kojic acid; oral tranexamic acid 250 mg BID or topical tranexamic acid 3-5% for refractory cases; chemical peels or laser toning (low-fluence 1064 Q-switched Nd:YAG) for persistent PIH under dermatologist supervision. Resolution typically 2-6 months. Sources: Ogunbiyi A 2019, Clin Cosmet Investig Dermatol; Lanigan 2006. Confidence: C2.

Hypopigmentation

Hypopigmentation — the loss of melanin-producing function in the treated field — is less common than PIH but more often permanent. Mechanism: over-treatment destroys melanocytes along with follicles. More common with shorter-wavelength lasers (ruby, alexandrite) on darker skin, with burns, and with over-treatment of the same area in repeated sessions. Rare with properly-calibrated Nd:YAG. Management: observe; some cases repigment spontaneously over 6-12 months, but permanent hypopigmentation is common. Topical treatments (pseudocatalase, photochemotherapy) have limited evidence for cosmetic repigmentation. Prevention is the only reliable intervention: appropriate wavelength selection, moderate fluences, adequate cooling. Confidence: C2.

Scarring

Hypertrophic or atrophic scarring is rare with laser hair removal — reported in well under 1% of courses — and is almost always a consequence of a prior burn, of keloid diathesis, or of infection in the post-session period. Keloid-prone patients (especially Fitzpatrick V-VI with personal or family history of keloids) should have a test spot performed before committing to a full course. Confidence: C2.

Mole and nevus changes

Melanocytic nevi in the treated field can fade or change dermatoscopic features after laser exposure. The clinical concern is that a laser-modified nevus loses its baseline dermoscopic signature, making subsequent melanoma surveillance more difficult. No case of laser-induced melanoma has been documented in 30+ years of clinical use. Standard practice: baseline dermoscopy before laser of any area with significant nevi; consider avoiding large atypical nevi; document any nevus that changes appearance post-laser. Sources: Lanigan 2006; dermatology practice guidelines. Confidence: C2.

Non-physician operator litigation

Across US laser hair removal litigation from 2012-2020, 75% of lawsuits involved non-physician operators; laser hair removal was the most litigated procedure (64% of all laser-surgery cases). Burns and PIH accounted for 47% of complaints. State regulation of who can legally operate a hair-removal laser varies widely: some states require physician operation or physician-supervised nurse; some allow unlicensed technicians with minimal training. The non-physician operator correlation is not evidence that non-physician operators are inherently unsafe — many skilled technicians produce excellent results — but is consistent with the fact that physicians have higher training requirements and tighter licensing oversight. Patients selecting a clinic on complication risk should consider operator qualification as one factor among several. Sources: Dermatology Times non-physician operator study. Confidence: C2.